Free Trial

Nuvation Bio (NUVB) Insider Trading & Ownership

Nuvation Bio logo
$2.67 -0.01 (-0.37%)
(As of 05:26 PM ET)

Nuvation Bio (NYSE:NUVB) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
5.07%
Number Of
Insiders Buying
(Last 12 Months)
3
Amount Of
Insider Buying
(Last 12 Months)
$1.99 M
Number Of
Insiders Selling
(Last 12 Months)
0
Get NUVB Insider Trade Alerts

Want to know when executives and insiders are buying or selling Nuvation Bio stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

NUVB Insider Buying and Selling by Quarter

Nuvation Bio Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/8/2024Robert MashalDirectorBuy100,000$2.20$220,000.00  
6/24/2024Xiangmin CuiDirectorBuy336,874$2.98$1,003,884.52  
6/20/2024Xiangmin CuiDirectorBuy87,715$2.99$262,267.85  
6/11/2024Kim D BlickenstaffDirectorBuy172,189$2.90$499,348.10  
(Data available from 1/1/2013 forward)

NUVB Insider Trading Activity - Frequently Asked Questions

The list of insiders at Nuvation Bio includes Fund V L.P. Omega, Kathryn E Falberg, Kim D Blickenstaff, Oleg Nodelman, Robert Mashal, and Xiangmin Cui. Learn more on insiders at NUVB.

5.07% of Nuvation Bio stock is owned by insiders. Learn more on NUVB's insider holdings.

The following insiders have purchased NUVB shares in the last 24 months: Kim D Blickenstaff ($499,348.10), Oleg Nodelman ($6,552,260.00), Robert Mashal ($220,000.00), and Xiangmin Cui ($1,266,152.37).

Insiders have purchased a total of 5,892,778 NUVB shares in the last 24 months for a total of $8,537,760.47 bought.

Nuvation Bio Key Executives

  • Dr. David T. Hung M.D.Dr. David T. Hung M.D. (Age 66)
    Founder, President, CEO & Director
    Compensation: $1M
  • Dr. Gary Hattersley Ph.D. (Age 57)
    Chief Scientific Officer
    Compensation: $694.56k
  • Dr. David Liu M.D. (Age 54)
    Ph.D., Chief Medical Officer
    Compensation: $677.15k
  • Mr. Moses Makunje CPA (Age 45)
    VP of Finance and Principal Accounting & Financial Officer
  • Ms. Stacy Markel (Age 59)
    Chief People Officer
  • Dr. David C. Hanley Ph.D. (Age 54)
    Chief Technical Operations Officer
    Compensation: $586.04k
  • Ms. Kerry A. Wentworth (Age 51)
    Chief Regulatory Officer
  • Ms. Colleen Sjogren (Age 54)
    Chief Commercial Officer
  • Dr. Junyuan Wang Ph.D. (Age 51)
    CEO & Co-Founder of AnHeart Therapeutics and Director


This page (NYSE:NUVB) was last updated on 12/23/2024 by MarketBeat.com Staff
From Our Partners